Editing Guidelines (section)

== CUA Guidelines ==

=== Oncology ===

==== Prostate ====

* [[CUA: Castrate-resistant Prostate Cancer (2021)|Castrate-resistant Prostate Cancer (2021)]]
* [[CUA: Androgen Deprivation Therapy: Adverse Events & Management (2021)|Androgen Deprivation Therapy: Adverse Events & Management (2021)]]
* [[CUA: Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)|Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)]]
* [[CUA: Testosterone Suppression (2018)|Testosterone Suppression (2018)]]
* [[CUA: Prostate Cancer Screening (2017)|Prostate Cancer Screening (2017)]]
* [[Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017)]]
* [[CUA: Prostate Cancer Active Surveillance (2015)|Prostate Cancer Active Surveillance (2015)]]

==== Bladder ====

* [[CUA & AUA: Non-muscle Invasive Bladder Cancer (2021 CUA & 2020 AUA)|Non-muscle Invasive Bladder Cancer (2021)]]
* [[CUA: Advanced and Metastatic Urothelial Cancer (2019)|Advanced and Metastatic Urothelial Cancer (2019)]]
* [[CUA: Muscle-invasive Bladder Cancer (2019)|Muscle-invasive Bladder Cancer (2019)]]
* [[CUA: Asymptomatic Microscopic Hematuria (2008)|Asymptomatic Microscopic Hematuria (2008)]]

==== Kidney ====

* [[CUA: Follow-up Localized RCC (2018)|Follow-up Localized RCC (2018)]]
* [[CUA: Cystic Renal Lesions (2017)|Cystic Renal Lesions (2017)]]
* [[CUA: Small Renal Masses (2015)|Small Renal Masses (2015)]]
* [[CUA: Surgical Management of RCC (2014)|Surgical Management of RCC (2014)]]
* [[CUA: RCC Genetic Screening (2013)|RCC Genetic Screening (2013)]]

=== Non-oncology ===

==== Andrology ====

* [[CUA: Peyronie's Disease (2018)|Peyronie's Disease (2018)]]
* [[AUA & CUA: Erectile Dysfunction (2021 CUA, 2018 AUA)|Erectile Dysfunction (2021)]]

==== Functional ====

* [[CUA: Neurogenic Lower Urinary Tract Dysfunction (2019)|Neurogenic Lower Urinary Tract Dysfunction (2019)]]
* [[CUA: Male LUTS & BPH (2018)|Male LUTS/BPH (2018)]]
* [[AUA & CUA Mesh Position Statement (2019)|CUA/AUA Mesh Position Statement (2019)]]
* [[CUA: Overactive Bladder (2017)|Overactive Bladder (2017)]]

==== Infections and Inflammation ====

* [[AUA & CUA Recurrent UTI (2019)|CUA/AUA Recurrent UTI (2019)]]
* [[CUA: Antibiotic Prophylaxis (2015)|Antibiotic Prophylaxis (2015)]]
* [[CUA: Chronic Scrotal Pain (2018)|Chronic Scrotal Pain (2018)]]
* [[CUA: Interstitial Cystitis (2016)|Interstitial Cystitis (2016)]]

==== Infertility ====

* [[CUA: Azoospermia (2015)|Azoospermia (2015)]]

==== Pediatrics ====

* [[CUA: Circumcision (2018)|Circumcision (2018)]]
* [[CUA: Antenatal hydronephrosis (2017)|Antenatal hydronephrosis (2017)]]
* [[CUA: Cryptorchidism (2017)|Cryptorchidism (2017)]]
* [[CUA: Multicystic Dysplastic Kidney in the Neonate (2015)|Multicystic Dysplastic Kidney in the Neonate (2015)]]

==== Stones ====

* [[CUA: Evaluation and Medical Management of Stones (2016)|Evaluation and Medical Management of Stones (2016)]]
* [[CUA: Ureteral Calculi (2015)|Ureteral Calculi (2015)]]

==== Other ====

* [[AUA & CUA: Vasectomy (AUA 2015, CUA 2022)|Vasectomy (2022)]]
* [[CUA: Adrenal Mass (2011)|Adrenal Mass (2011)]]
* [[CUA: Radiation-induced Hemorrhagic Cystitis (2018)|Radiation-induced Hemorrhagic Cystitis (2018)]]
* [[CUA: VTE Prophylaxis (2019)|VTE Prophylaxis (2019)]]
*[[CUA: Vasectomy (2016)|Vasectomy (2016)]]

==== Contribute ====

*Ureteral calculi (2022)
* Pediatric bladder dysfunction (2021)
* Sporadic angiomyolipomas (2020)
* Male urethral stricture (2020)
* Catheter use (2020)
* Renal mass biopsy (2019)
* Pheochromocytoma surveillance (2019)
* Pediatric hemorrhagic cystitis (2019)